ARV/ART

Resource
March 21, 2019

INTRODUCTION: Since June 2016, the national HIV programme in Malawi has adopted Universal Test and Treat (UTT) guidelines requiring that all persons who test HIV positive will be referred to start antiretroviral therapy (ART).

Resource
March 19, 2019

BACKGROUND:

People living with HIV (PLHIV) are at increased risk of tuberculosis (TB). TB is also the leading opportunistic infection contributing to about one-third of deaths in this population. The World Health Organization recommends regular screening for TB in PLHIV.

Resource
March 12, 2019
In this study, we aimed to study retention in care trajectories and associated factors in ART-eligible patients enrolled in a universal test-and-treat trial implemented in rural South Africa.
Resource
March 5, 2019

Despite advances in prevention, diagnosis and treatment of tuberculosis and human immunodeficiency virus (HIV), tuberculosis remains the leading cause of death and illness among people living with HIV.

Blog
February 26, 2019

The first-ever UN high level meeting on tuberculosis (TB) on 26 September 2018 in New York was a crucial political moment for TB.

Resource
February 21, 2019

We assessed the relationship between distance to clinic and progression through the HIV care cascade. We have two key findings. First, distance matters but only for women. Second, for women, distance affected linkage to care, but was not associated with later transitions in the care cascade.

Resource
February 21, 2019
Depression is a leading cause of disability and may be associated with decreased adherence to ART. We sought to describe the prevalence of depressive symptoms and outcomes one year after screening among patients receiving ART at a large HIV Clinic in Johannesburg, South Africa.
Resource
February 12, 2019

Professor Quarraisha Abdool Karim is one of the world’s leading AIDS researchers and has made pioneering contributions to understanding the HIV epidemic in young people, especially among young women.

Resource
February 12, 2019

This report presents the preliminary findings from an ongoing project undertaken by 4Children that seeks to identify key opportunities to incorporate violence prevention and response interventions within priority PEPFAR Program Areas at clinical and community levels.

Resource
February 5, 2019

Update on recommendations on antiretroviral regimens for treating and preventing HIV infection: In 2016, WHO published the consolidated guidelines on the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and recommended tenofovir disoproxil fumarate (TDF